PACKAGE LABEL - Zepbound Prefilled Pen (Autoinjector) - 2.5 mg/0.5 mL Dose PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 0002-2506-80 Zepbound (tirzepatide) injection 2.5 mg/0.5 mL 4 x 2.5 mg/0.5 mL prefilled pens Rx Only For Subcutaneous Use Dispense enclosed Medication Guide to each patient
But if there is any doubt at all, call your pharmacist or provider before drawing up
Consider using a small plastic container to keep vials organized and prevent them from rolling against the back wall where they might freeze
Troy Watson combines this medication with personalized guidance on diet, exercise, and lifestyle to ensure lasting results
Certain factors may increase susceptibility to burping and related gastrointestinal symptoms, including: Rapid dose escalation (not following the recommended titration schedule) Concurrent use of other medications affecting gut motility (such as opioids or anticholinergics) Pre-existing gastrointestinal conditions such as gastroparesis or gastroesophageal reflux disease (GERD) Dietary habits that promote gas production Gastrointestinal adverse effects, including burping, are generally more common and pronounced at higher doses, which explains the higher rates observed with Wegovy compared to Ozempic
